HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NPA Offers Trump Administration Supplement Industry Shopping List

This article was originally published in The Rose Sheet

Executive Summary

NPA CEO Daniel Fabricant provides 2011 sales statistics for the natural product and dietary supplement sectors and encourages the Trump administration to allow NPA to work closely with FDA on a guidance for NDI notifications.

You may also be interested in...



International Drives C&D Sales, NPA On WIC, Recalls: Health And Wellness Industry News

Church & Dwight reports 12% growth in consumer business abroad; functional foods marketer Soylent receives $50m in funding round; Herbalife Protein Bar – Peanut Butter and other recalls; and more news in brief.

DEA Proposal To Schedule Kratom Stirs Wave Of Opposition

AHPA and the American Botanical Council are among the opponents of DEA's proposal to schedule the active materials in kratom while NPA supports it, saying kratom products and raw ingredients have not met "the strict standards products and new ingredients must adhere to in order to be marketed to the public."

Revised NDI Notification Draft Guidance Shrinks Divide Between FDA And Industry

More than four years after beginning to revise its widely criticized initial draft guidance on NDI notifications, FDA on Aug. 11 released a second draft. "I think it is reflective of a new effort by the agency to have a dialogue with the industry," says Steve Mister, president and CEO of the Council for Responsible Nutrition.

Topics

UsernamePublicRestriction

Register

RS109021

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel